Inspire and Empower Members to Promote Access to and Delivery of Quality Healthcare

Advances in Cardio-Metabolic-Renal Management of Patients with Type 2 Diabetes

CE Information
1.5 contact hours (1.5 pharmacology)
Completion Time
1 hour, 30 minutes
Available Until
August 1, 2025
Ready to start this activity?
Login required. You will be redirected to an external website to register for and complete this activity.

Overview

Specialties
Adult, Family, and Gerontological
Clinical Topics
Cardiovascular Disease, Diabetes, and Metabolic Disorders

This 1.5 hour presentation covers "Advances in Cardio-Metabolic-Renal Management of Patients with Type 2 Diabetes".

Learning Objectives

This presentation will cover the following objectives:

1. Distinguish at least 3 (three) key recommendations from the current standard of practice guidelines to determine the best cardio-metabolic-renal therapeutic approaches for glycemic control in T2DM patients. (RX)

2. Identify key cardio-metabolic-renal pharmacology strategies from the clinical process algorithm designed to impact at least 3 core defects of diabetes positively. (RX)

3. Through case application, apply cardio-metabolic-renal principles to treatment plans for special populations with type 2 diabetes to achieve glycemic control. (RX)

Speakers

Kathleen Wilson
Kathleen Wilson PhD, ARNP-C, FAANP

Clinician/Endocrinology Specialist, Graduate Faculty, & NP Consultant

CE Information

This activity offers 1.5 contact hours (1.5 pharmacology) to attendees.

Accredited by AANP.

This activity is approved for 1.5 contact hour(s) of continuing education (which includes 1.5 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 24086790. This activity was planned in accordance with AANP Accreditation Standards and Policies.


Ready to start this activity?

Login required. You will be redirected to an external website to register for and complete this activity.

Log in and start activity